Thomas Patrick Reeves
Vorstandsvorsitzender bei Interface Biologics, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Paul J. Santerre | M | - |
Interface Biologics, Inc.
 Interface Biologics, Inc. Information Technology ServicesTechnology Services Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada. | 23 Jahre |
| Arthur Rosenthal | M | 77 |
Interface Biologics, Inc.
Interface Biologics, Inc. Information Technology ServicesTechnology Services Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada. | 15 Jahre |
| Michael Berg | M | 71 | 18 Jahre | |
| Phil R. Reddon | M | 58 |
Interface Biologics, Inc.
Interface Biologics, Inc. Information Technology ServicesTechnology Services Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada. | - |
| Pieter Wolters | M | - |
Interface Biologics, Inc.
Interface Biologics, Inc. Information Technology ServicesTechnology Services Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada. | - |
| Dion Madsen | M | 56 |
Interface Biologics, Inc.
Interface Biologics, Inc. Information Technology ServicesTechnology Services Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada. | - |
| Jeannette Ho | F | - |
Interface Biologics, Inc.
Interface Biologics, Inc. Information Technology ServicesTechnology Services Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada. | - |
| Sandra Lin | F | 66 |
Interface Biologics, Inc.
Interface Biologics, Inc. Information Technology ServicesTechnology Services Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada. | 12 Jahre |
| Defne Garner | F | - |
Interface Biologics, Inc.
Interface Biologics, Inc. Information Technology ServicesTechnology Services Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada. | - |
| John Denstedt | M | - |
Interface Biologics, Inc.
Interface Biologics, Inc. Information Technology ServicesTechnology Services Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada. | - |
| Rosalind Labow | F | - |
Interface Biologics, Inc.
Interface Biologics, Inc. Information Technology ServicesTechnology Services Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada. | - |
| Bradley Strauss | M | - |
Interface Biologics, Inc.
Interface Biologics, Inc. Information Technology ServicesTechnology Services Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada. | - |
| Steve Zmina | M | - | 18 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| William G. Dumencu | M | 68 | 12 Jahre | |
| John Caloz | M | 72 | 2 Jahre | |
| Stephen G. Zmina | M | 70 | - | |
| Donald Rindell | M | 72 | 12 Jahre | |
| Richard Lindstrom | M | 76 | 16 Jahre | |
| Adrienne Graves | M | 69 | 13 Jahre | |
| Robert Walder | M | 71 | - | |
| Jay T. Holmes | M | 81 | 4 Jahre | |
| Gil Omenn | M | 83 | 3 Jahre | |
| Thomas N. Davidson | M | 83 | 6 Jahre | |
| Joseph Zawaideh | M | - | 1 Jahre | |
| Irving J. Siegel | M | - | - | |
| Nozait Chaudry-Rao | M | - | 2 Jahre | |
| Douglas P. Adams | M | - | 1 Jahre | |
| Steve Westing | M | - | 2 Jahre | |
| Stephen B. Parks | M | - | 3 Jahre | |
| Frank Shannon | M | - |
Interface Biologics, Inc.
Interface Biologics, Inc. Information Technology ServicesTechnology Services Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada. | - |
| John Cornish | M | - | 11 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 19 | 61,29% |
| Kanada | 12 | 38,71% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Thomas Patrick Reeves
- Persönliches Netzwerk